Abstract:Background: Esophageal squamous cell carcinoma (ESCC) is the fourth most common cause of cancer death in China. Long noncoding RNAs have emerged as critical regulators in cancer. Long intergenic noncoding RNA-p21, a kind of Long noncoding RNAs, LincRNA-p21 have been discussed dysregulated in several cancers, but its role in ESCC remains unknown. This study investigated the role of LincRNA-p21 in ESCC. Materials and methods: The LincRNA-p21 expression level and its association with esophageal cancer was determined in 64 tumor tissues of esophageal squamous cell carcinoma patients and cells using quantitative real-time reverse transcription PCR. Fluorescence in situ hybridization of single-RNA molecular probes was used to determine subcellular localization of LincRNA-p21. CCK8 and EdU assays were used for proliferation assay, flow cytometry was performed for apoptosis and cell-cycle distribution, and 24-well Mill cell chamber was made for measuring the abilities of migration and invasion after transfected with lentivirus-expressing LincRNA-p21 in EC109 cells. Then, quantitative real-time reverse transcription PCR and Western blot detected the expression of p21. Further, UC2288, an inhibitor of p21, was used to decrease the level of p21, and flow cytometry was used to detect cell cycle. Finally, screening for differential pathways from microarray analysis and expression of p53 and cyclin D were detected by Western blot. Results: LincRNA-p21 expression level was remarkably lower in tumor tissues versus nontumor tissues and lower in EC109 cells versus Het-1A cells. Statistical analysis found that LincRNA-p21 might enhance the risk of ESCC. We observed that LincRNA-p21 was expressed both in the nucleus and cytoplasm, and a larger proportion of LincRNA-p21 was observed in the cytoplasm. The results demonstrated that upregulating the expression of LincRNA-p21 could inhibit cell proliferation, migration, invasion, and the transition of cell cycle from G1 and promoted apoptosis of EC109. Then, we found that LincRNA-p21 promotes the expression of p21. Decreasing the level of p21 revealed that cell-cycle arrest was restored. Pathway analysis found p53 pathway was downregulated, and upregulation of LincRNA-p21 inhibited the expression of cyclin D. Conclusion: Our study suggests that LincRNA-p21 plays as a tumor inhibitor in ESCC development and LincRNA-p21 might induce G1 arrest through p53 signal pathway.

Long Intergenic Noncoding RNA-p21 Inhibits Apoptosis by Decreasing PUMA Expression in Non-Small Cell Lung Cancer.

Lincrna‑p21 Inhibits the Progression of Non‑small Cell Lung Cancer Via Targeting Mir‑17‑5p

LncRNA LINC00525 suppresses p21 expression via mRNA decay and triplex‐mediated changes in chromatin structure in lung adenocarcinoma

Long intragenic non-coding RNA lincRNA-p21 suppresses development of human prostate cancer.

Lincrna-P21 Regulates Neointima Formation, Vascular Smooth Muscle Cell Proliferation, Apoptosis, and Atherosclerosis by Enhancing P53 Activity

Long Noncoding RNA LINC00961 Inhibits Cell Proliferation and Induces Cell Apoptosis in Human Non–small Cell Lung Cancer

Effect of Long Intergenic Noncoding RNA-p21 Knockdown on Radiosensitivity of Hypoxic Tumor Cells

LincRNA-p21 Knockdown Enhances Radiosensitivity of Hypoxic Tumor Cells by Reducing Autophagy Through HIF-1/Akt/mTOR/P70S6K Pathway

Up-Regulated Expression of Pro-Apoptotic Long Noncoding RNA lincRNA-p21 with Enhanced Cell Apoptosis in Lupus Nephritis

Long intergenic non-coding RNA APOC1P1-3 inhibits apoptosis by decreasing α -tubulin acetylation in breast cancer

p53-targeted lincRNA-p21 acts as a tumor suppressor by inhibiting JAK2/STAT3 signaling pathways in head and neck squamous cell carcinoma

RETRACTED: Linc01088 Promotes Cell Proliferation by Scaffolding EZH2 and Repressing P21 in Human Non-Small Cell Lung Cancer

Long Non-Coding RNA SOX21-AS1 Modulates Lung Cancer Progress Upon Microrna Mir-24-3p/pim2 Axis.

LincRNA-p21 Promotes Cellular Senescence by Down-regulating the Wnt/β-catenin Pathway in MPP+-treated SH-SY5Y Cells

LincRNA-p21 Leads to G1 Arrest by P53 Pathway in Esophageal Squamous Cell Carcinoma.

Long noncoding RNA AFAP1-AS1 predicts a poor prognosis and regulates non–small cell lung cancer cell proliferation by epigenetically repressing p21 expression

Long Non-Coding RNA LINC00672 Contributes to P53 Protein-Mediated Gene Suppression and Promotes Endometrial Cancer Chemosensitivity

Long Noncoding RNA PANDAR Inhibits the Development of Lung Cancer by Regulating Autophagy and Apoptosis Pathways.

Suppression of Long Non-Coding RNA UCA1 Inhibits Proliferation and Invasion and Induces Apoptosis in Human Lung Cancer Cells.

Advances in Mechanism of LincRNA-p21 in Cancer

Downregulation of LINC01296 Suppresses Non-Small-cell Lung Cancer Via Targeting Mir-143-3p/atg2b.